Web Results

www.nature.com/articles/pcan201340

Oct 8, 2013 ... PSA doubling time (PSADT) is an attractive intermediate end point for ... PSA measurements for PSADT calculation before enrollment and at ...

www.medicine.mcgill.ca/epidemiology/joseph/publications/Methodological/bellera.pdf

estimate the PSA doubling time (PSAdt), a major predictor of treatment outcomes (1–8). ... First, it avoids having to actually calculate the log2 of each. PSA ...

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.556.5497&rep=rep1&type=pdf

automatically. Abstract. Objectives: To review the methodology of PSA doubling time (PSA DT) ... cut points of PSA DT. Optimal time intervals for calculation and.

onlinelibrary.wiley.com/doi/full/10.1111/bju.13856

Mar 28, 2017 ... All PSA values 2 years after CRPC diagnosis but before the development of metastasis were used to calculate PSADT. This calculation required ...

onlinelibrary.wiley.com/doi/full/10.1002/ijc.22161

Sep 29, 2006 ... PSA doubling time (PSADT) was calculated based on PSA ... at time of last follow ‐up or death due to other causes) and to calculate PSA‐free ...

riskofrisingpsa.com

In one study, men with CRPC and a PSA doubling time (PSADT) <3 months developed ... Use the PSA doubling time calculator provided by the Memorial Sloan ...

ascopubs.org/doi/10.1200/JCO.2006.08.0572

Sep 21, 2016 ... ... prostate-specific antigen doubling time (PSADT) was associated with ... had data available to calculate PSADT (≥ two PSA values separated ...

www.oncotarget.com/article/27088/text

Aug 20, 2019 ... Several methods of its calculation were proposed: flow cytometry, ... PSAD - PSA doubling time; CLF - cell loss factor; PSA -prostatic specific ...

www.hematologyandoncology.net/archives/january-2013/management-of-biochemically-recurrent-prostate-cancer-after-local-therapy-evolving-standards-of-care-and-new-directions

... death is the PSA doubling time (PSADT), a mathematical determination of the ... 3 months apart is considered a reliable foundation for calculation of PSADT.

www.renalandurologynews.com/home/news/urology/prostate-cancer/psa-doubling-time-predicts-metastasis-mortality-risks-in-crpc

Apr 10, 2017 ... The median times to metastasis were 9, 19, 40, and 50 months for patients with a PSADT of less than 3, 3–8, 9–14.9, and 15 months or more, ...